跳至主要内容
临床试验/CTIS2023-504577-21-00
CTIS2023-504577-21-00进行中(未招募)1 期

A phase IV, unicentric, open label clinical trial to evaluate the default mode network in multiple sclerosis patients on Cladribine treatment. - CLADRI_NET

María Luisa Martínez Ginés0 个研究点目标入组 20 人开始时间: 2023年3月23日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • MS diagnostic following McDonald 2010 diagnosis criteria., Age between 30 and 55 years old., MS patients that started treatment with cladribine tablets in the last month., Consent form signature

排除标准

  • Dementia diagnosis, following Spanish Neurological Society criteria., Mayor psychiatric illness., Physical or intellectual limitations to successfully perform neuropsychological evaluation., Any other circumstance that may interfere with functional magnetic resonance session, Abnormal renal function previous to MRI session., Pregnant or breastfeeding females or males and females of childbearing potential not willing to use a medically acceptable contraceptive method from enrolment until six months after the end of the treatment

研究者

发起方
María Luisa Martínez Ginés

相似试验

进行中(未招募)
1 期
A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in patients with cutaneous lesions in scleroderma diseases.Fibrotic and atrophic cutaneous lesions in localized scleroderma diseases.MedDRA version: 20.0Level: HLTClassification code 10039711Term: Scleroderma and associated disordersSystem Organ Class: 100000004870
EUCTR2015-005100-28-ITMASTELLI SR45
已完成
4 期
A clinical study to see the effect and safety of Phenocaine Plus Injection in Cataract Surgery.
CTRI/2021/04/032545Entod Pharmaceuticals Ltd
已完成
4 期
A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.
CTRI/2011/07/001890Procter and Gamble50
进行中(未招募)
不适用
Evaluation of the long-term persistence of hepatitis A antibodies in healthy adults who were vaccinated 21-25 years earlier with GlaxoSmithKline (GSK) Biologicals’ hepatitis A vaccine, Havrix®.Healthy volunteers (Vaccination against hepatitis A in healthy adults)MedDRA version: 16.1Level: LLTClassification code 10052551Term: Hepatitis A virusSystem Organ Class: 100000004848
EUCTR2013-001918-15-BEGlaxoSmithKline Biologicals
进行中(未招募)
不适用
A phase IV, open-label, multi-centre trial evaluating the conversion from standard phosphate binder therapy to Fosrenol in chronic kidney disease stage 5 patients on haemodialysisHyperphosphataemia in patients with chronic kidney disease stage 5 receiving haemodialysisMedDRA version: 8.1Level: LLTClassification code 10020712Term: Hyperphosphatemia
EUCTR2006-003364-64-ATShire Pharmaceutical Development Ltd760